These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16835406

  • 1. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
    Pérez-Rojas J, Blanco JA, Cruz C, Trujillo J, Vaidya VS, Uribe N, Bonventre JV, Gamba G, Bobadilla NA.
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
    [Abstract] [Full Text] [Related]

  • 2. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity.
    Pérez-Rojas JM, Derive S, Blanco JA, Cruz C, Martínez de la Maza L, Gamba G, Bobadilla NA.
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1020-30. PubMed ID: 15998842
    [Abstract] [Full Text] [Related]

  • 3. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
    Sánchez-Pozos K, Lee-Montiel F, Pérez-Villalva R, Uribe N, Gamba G, Bazan-Perkins B, Bobadilla NA.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
    [Abstract] [Full Text] [Related]

  • 4. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
    Macunluoglu B, Arikan H, Atakan A, Tuglular S, Ulfer G, Cakalagaoglu F, Ozener C, Akoglu E.
    Transplant Proc; 2008 Jul; 40(1):273-8. PubMed ID: 18261605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.
    Mejía-Vilet JM, Ramírez V, Cruz C, Uribe N, Gamba G, Bobadilla NA.
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F78-86. PubMed ID: 17376767
    [Abstract] [Full Text] [Related]

  • 8. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 9. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
    Hagar HH, El Etter E, Arafa M.
    Clin Exp Pharmacol Physiol; 2006 Mar 28; 33(3):189-96. PubMed ID: 16487261
    [Abstract] [Full Text] [Related]

  • 10. Expression of transforming growth factor-beta and determination of apoptotic index in histopathological sections for assessment of the effects of Apigenin (4', 5', 7'- Trihydroxyflavone) on Cyclosporine A induced renal damage.
    Chong FW, Chakravarthi S, Nagaraja HS, Thanikachalam PM, Lee N.
    Malays J Pathol; 2009 Jun 28; 31(1):35-43. PubMed ID: 19694312
    [Abstract] [Full Text] [Related]

  • 11. [The effect of an antioxidant tea polyphenols on cell apoptosis in rat model of cyclosporine-induced chronic nephrotoxicity].
    Shi S, Zheng S, Jia C, Zhu Y, Xie H.
    Zhonghua Wai Ke Za Zhi; 2002 Sep 28; 40(9):709-12. PubMed ID: 12411148
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of tea polyphenols on renal cell apoptosis in rat test subjects suffering from cyclosporine-induced chronic nephrotoxicity.
    Shi S, Zheng S, Zhu Y, Jia C, Xie H.
    Chin Med J (Engl); 2003 Sep 28; 116(9):1345-50. PubMed ID: 14527363
    [Abstract] [Full Text] [Related]

  • 13. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M, Burke JF, McGowan TA, Zhu Y, Dunn SR, McCue P, Kanalas J, Sharma K.
    Kidney Int; 2001 Feb 28; 59(2):498-506. PubMed ID: 11168932
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity.
    Shi SH, Zheng SS, Jia CK, Zhu YF, Xie HY.
    Acta Pharmacol Sin; 2004 Jan 28; 25(1):98-103. PubMed ID: 14704129
    [Abstract] [Full Text] [Related]

  • 16. The effect of aldosterone antagonist in experimental nephropathy induced by cyclosporine A.
    Silva FM, Miorin LA, Sens YA.
    Ren Fail; 2008 Jan 28; 30(4):439-42. PubMed ID: 18569919
    [Abstract] [Full Text] [Related]

  • 17. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS, Yi H, Bennett WM, Andoh TF.
    Kidney Int; 2000 Sep 28; 58(3):1174-85. PubMed ID: 10972680
    [Abstract] [Full Text] [Related]

  • 18. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
    Bobadilla NA, Gamba G.
    Am J Physiol Renal Physiol; 2007 Jul 28; 293(1):F2-9. PubMed ID: 17429034
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats.
    Nielsen FT, Jensen BL, Marcussen N, Skøtt O, Bie P.
    Nephrol Dial Transplant; 2008 Sep 28; 23(9):2777-83. PubMed ID: 18424460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.